Clinical Trial: TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors

U.S., Jan. 31 -- ClinicalTrials.gov registry received information related to the study (NCT06801041) titled 'TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors' on Jan. 24.

Brief Summary: This clinical research study is to learn about the feasibility, safety, and effects of psilocybin-assisted psychotherapy for cancer survivors with depression and/or anxiety.

Study Start Date: June 01, 2025

Study Type: INTERVENTIONAL

Condition: Depression Anxiety Cancer

Intervention: DRUG: Psilocybin

Participants will recive treatment by mouth on an outpatient basis.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: M.D. Anderson Cancer Center

Published by HT Digital Content Services w...